Resource Tracking News Today

The latest findings from the Global Burden of Disease Study (GBD) forecast that global life expectancy will increase by 4.9 years in males and 4.2 years in females between 2022 and 2050.

The latest findings from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, published today in The Lancet, provide new insights into health challenges and the risk factors that are driving them.

Global life expectancy increased by 6.2 years since 1990 according to a new study published in The Lancet.

A new study published in The Lancet reveals never-before-seen details about staggeringly high mortality from the COVID-19 pandemic within and across countries.

It took less than a year for researchers to develop a vaccine against Covid-19. The search for an HIV vaccine began almost 40 years ago. The unprecedented pace at which the Covid-19 jabs were developed and the scientific breakthroughs they required have re-energised those efforts to develop an HIV vaccine. But they have also raised critical questions about what could have been if the search for an HIV vaccine had met with the same resources and political will as the coronavirus pandemic. Consid...

Towards an HIV Cure MISSION: To drive concerted efforts to accelerate global scientific research and engagement towards a cure for HIV. The toolbox of interventions for fighting the global HIV pandemic has grown exponentially since the discovery of the virus, but a cure has remained beyond our grasp. In recent years, however, research to develop a cure for HIV or long-term remission has made promising progress, galvanizing researchers, advocates and community members alike. To that end, the mis...

National February 6, 2021 LAHORE: Global funding for COVID-19 vaccine development has exceeded 10 times in less than a year the amount allocated for HIV and TB research and development in 11 years. “A staggering amount of $103.8 billion has been thrust into COVID-19 vaccine development within a period of just 11 months of 2020 as compared to a paltry $9.5 billion ($8.5 billion for HIV and $1billion for TB) for HIV and TB research and vaccine development during 11-year period from 2009 to 201...